STD & Sexual Health Testing News
The latest developments in STD/STI testing technology, public health guidance, and access programs.
CDC Set to Finalize 2024 STI Data in 2026, Confirming Third Straight Year of Decline
January 12, 2026
CDC's provisional 2024 STI surveillance data shows chlamydia, gonorrhea, and syphilis cases fell 9% from 2023 — the third consecutive year of decline — with final 2024 figures expected in 2026.
Read More →At-Home STI Testing Options Have Expanded Sharply — Here's What's Now Available
January 19, 2026
From a 30-minute at-home chlamydia/gonorrhea/trichomoniasis test to a 1-minute HIV self-test, FDA-authorized at-home STI testing options have expanded significantly in the past year.
Read More →Doxy-PEP Adoption Grows, But 2026 Guidance Requires Regular STI Screening to Go With It
January 26, 2026
Doxycycline post-exposure prophylaxis (doxy-PEP) continues to expand as a bacterial STI prevention strategy, but 2026 clinical guidance ties it to mandatory quarterly testing.
Read More →CDC Updates Gonorrhea Treatment Guidelines as Drug-Resistant Strains Spread
February 2, 2026
CDC has updated its gonorrhea treatment guidelines in 2026 to address a documented rise in ceftriaxone- and azithromycin-resistant strains, with the World Health Organization reporting a sixfold global increase in resistance.
Read More →Minnesota Genomic Surveillance Tracks New Gonorrhea Strain Behind Rising Disseminated Infections
February 9, 2026
Minnesota health officials used whole-genome sequencing to identify a new gonorrhea strain, ST16676, driving a near-fourfold rise in disseminated gonococcal infections.
Read More →Twice-Yearly HIV Prevention Shot Lenacapavir Expands to More Countries in 2026
February 16, 2026
The Global Fund and the U.S. government have expanded their commitment to scaling up lenacapavir, a twice-yearly injectable HIV prevention drug, aiming to reach 3 million people by 2028.
Read More →CDC's May 2026 HIV Data Shows Modest Care Improvements, But Testing Gaps Remain
February 23, 2026
New national data published by CDC in May 2026 shows slight improvements in HIV care and treatment outcomes, while officials continue to call for expanded testing access.
Read More →CDC Launches HepTracker Dashboard as 2026 Progress Report Shows Mixed Results on Hepatitis Elimination
March 2, 2026
CDC's new HepTracker dashboard and 2026 Viral Hepatitis National Progress Report show the U.S. has met half of its annual hepatitis elimination targets.
Read More →Congenital Syphilis Cases Rise for 12th Straight Year, Renewing Calls for Prenatal Screening
March 9, 2026
Congenital syphilis cases rose for a 12th consecutive year in 2024 data, with public health groups pointing to gaps in prenatal care access as a key driver.
Read More →Survey Finds Most Young Adults Prefer At-Home STI Testing Over Clinic Visits
March 16, 2026
A recent survey found 70% of young people would rather test for STIs at home than visit a clinic, as CDC data shows young adults continue to carry the largest share of new STI cases.
Read More →